Veytics Intelligence
2026-11-09 · Marketwatch

A failed trial for a heart drug casts shadow over rivals developing similar therapies

La traduction est en cours. L’article original est affiché.

The full data from the closely watched clinical trial showed that the drug had no cardiovascular benefit even though it reduced Lp(a) levels.

Lire le briefing complet de Veytics

Nous affichons publiquement l'idee principale. Creez un compte gratuit pour lire l'article complet, l'enregistrer, le commenter et le relier au contexte marches et OSINT.